Biliary Stents Market Size Worth $549.14 Million With CAGR Of 4.86% From 2022 To 2030 | Growth Plus Reports exclusive report
Newark, New Castle, USA, January 24, 2023 (GLOBE NEWSWIRE) —
According to the report published by Growth Plus Reports the Global
Biliary Stents Market
was estimated at
in 2021 and is expected to surpass an assessment of
progressing in a
CAGR of 4.86%
from 2022 to 2030. The report provides in-depth analysis of top winning strategies, drivers and opportunities, competitive landscape, changing market trends, market size, statistics and estimates, and major investment pockets.
Download PDF Brochure of Biliary Stents Market Size – Impact of COVID-19 and Global Analysis with Strategic Developments in:
The global biliary stent market has been evaluated from four different perspectives – product, application, end-user and region.
Excerpts from ‘By Product Segmentation’
The global biliary stent market is divided into two segments based on type:
The metallic biliary stent category witnessed the highest CAGR in 2021. Ease of insertion, greater patency due to large luminal diameters, decreased risk of displacement or migration, increased longevity, and widespread use in interventional endoscopy for various malignant obstructions are factors that contribute to the rapid growth of the segment. Due to the mesh, metal stents have two advantages over plastic stents: first, they do not obstruct the side branches; second, because most hilar tumors are solid and round, tumor ingrowth may occur less frequently. Based on their expandability, metallic stents are offered, which can also result in better customer acceptance due to greater benefits. The metallic biliary stent market has developed in 2021 due to expanding improvements in these devices. For example, if the patient’s remaining life expectancy is greater than 4-6 months, metallic stents are more cost-effective than plastic biliary stents. To treat malignant biliary blockage, bare metal stents are usually chosen over plastic ones.
Excerpts from ‘By Application Segmentation’
Depending on the applications, the global biliary stent market is segmented into:
benign biliary structures
The gallstone segment holds the largest share of the global gallstone stent market in 2021. One of the main reasons for the higher growth of this market is the increase in elderly population as gallstone disease is more common according to age. Before the age of 20, symptomatic calculous disease of the biliary tract is uncommon and, when it occurs, it often affects those with long-term risk factors such as cystic fibrosis or hemolytic anemia. In addition, gallstone disease has been linked to a variety of medications. Thus, the increased use of multiple drugs such as ceftriaxone, clofibrate, oral contraceptives, estrogen replacement, progestogens and octreotide are among the most frequently found culprits, mainly in the female population. Particularly in women, obesity is a substantial risk factor for gallstone disease. Obesity-related hypersecretion of cholesterol is a significant pathogenic factor. Increased leisure and strenuous exercise appear to decrease the risk of gallstones. Rapid weight loss on very low calorie diets has been linked to an increased risk of gallstone disease. Gallstones are becoming more common as a result of changing consumer preferences, growing health concerns and an increasing demand among consumers for a fit and healthy body. According to studies, those who follow weight loss regimens such as drastically reduced calorie diets or surgical weight loss treatments are more likely to develop gallstones than people who are not dieting. Therefore, the global emergence of gallstones is triggering the need for biliary stents as a treatment strategy.
Browse the full report with detailed TOC at:
Excerpts from ‘Region targeting’
On the basis of regions, the global biliary stents market is classified as:
Rest of the world
In 2021, North America controlled the world market. Some of the key aspects that will influence the growth of the regional market are the growing elderly population, which is more prone to diseases like pancreatic cancer, gallstones and other malignant obstructions. For example, the National Institutes of Health estimates that between 42 and 73 Americans out of every 100,000 have chronic pancreatitis. Additionally, according to the American Cancer Society, 62,210 people have been diagnosed with pancreatic cancer (32,970 men and 29,240 women) in recent years. Furthermore, the prevalence of gallstones among Pima Indians in Arizona is the highest in the world. Gallstone disease affects 90% of Pima women over 65 years of age. Gallstone disease is more common in men and women in Norway and Chile, as well as among Canadian Micmac Indians, Hispanics, and Mexican American women. In addition, the country’s citizens can more easily access hospital service acknowledgments to the region’s strong health infrastructure. North America has the most developed and reliable healthcare infrastructure, as well as stricter healthcare cost reimbursement rules, which helps explain North America’s dominance of the global biliary stent market. The number of super-specialty treatments available to treat the condition is increasing as more and more people have access to medical insurance. A boost to the industry is also being provided by recent research on biodegradable stents. The European region, like the American region, has conveniently accessible medical facilities and a large proportion of older citizens, both of which are expected to increase demand for stents in the market. As medical facilities are built in the Asia-Pacific region, the proportion of the elderly population grows and young people lead more sedentary lifestyles, the demand for biliary stents is predicted to increase.
Excerpts from ‘Competitive Scenario’
Major Companies Operating in the Global Biliary Stents Market Are:
Eckert & Ziegler BEBIG SA
boston medical products
B. Braun Melsungen AG
Cook Medical Inc.
Becton, Dickinson and Company
Merit Medical Systems, Inc.
Cook Medical Inc.
VALUE PROPOSALS RELATED TO THE REPORT
Built with hours of complimentary analysis and expert interviews on every report
Comprehensive quantitative and qualitative insights at the segment and sub-segment level
Trends and perspective of the impact of Covid 19
Granular insights at global/regional/country level
Deep-rooted insights into market dynamics (drivers, constraints, opportunities) and business environment
General coverage in the competitive landscape
Exhaustive coverage of ‘Strategic Developments’ recorded by major market players
Distributor scenario assessment
Customer Base Assessment
Analysis of Investments and Initiatives
‘Business profile’ of key players
Consult before buying:
Growth Plus Reports is part of GRG Health, a global health knowledge services company. We are proud to be members of the EPhMRA (European Pharmaceutical Marketing Research Association).
The Growth Plus portfolio of services draws on our core capabilities of secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and innovative solutions that set them up for growth. and future success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Manan Sethi Director, Market Insights Email: [email protected] Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/